Skip to main content
. 2020 Nov 25;147(2):517–531. doi: 10.1007/s00432-020-03463-9

Table 2.

Univariate and multivariate Cox proportional analysis for overall survival (cohort #2, N = 86)

n Univariate analysis Multivariate analysis
HR 95% CI P value HR 95% CI P value
Gender
 Male 55 1
 Female 31 0.819 0.488–1.374 0.448
Age (years)
 ≥ 65 36 1
 < 65 50 1.241 0.755–2.040 0.396
Location
 Head 54 1
 Other 32 1.155 0.701–1.903 0.571
Grading
 G1a 3
 G2 51 1 1
 G3 29 2.139 1.272–3.596 0.004 2.187 1.256–3.808 0.006
G4a 3
pStage
 I 11 1 1
 II 38 4.037 1.416–11.507 0.009 3.119 1.075–9.047 0.036
 III 30 3.694 1.274–10.717 0.016 3.501 1.184–10.353 0.023
 IV 7 5.452 1.524–19.497 0.009 3.585 0.938–13.706 0.062
Vascular invasion
 Yes 25 1
 No 61 1.349 0.805–2.262 0.256
Diameter (cm)
≥ 4 26 1
< 4 60 0.836 0.498–1.402 0.497
Procedure
 PD 50 1
 DP 27 1.149 0.670–1.969 0.613
 TP 9 1.149 0.484–2.728 0.752
Postoperative chemotherapy
 No 47 1 0.270–0.750 0.329–1.022
 Yes 39 0.450 0.002 0.580 0.06
VISTA in TCs
 Low 65 1 1
 High 21 0.535 0.290–0.987 0.045 0.481 0.246–0.943 0.033
VISTA in ICs
 Low 56 1
 High 30 1.092 0.655–1.822 0.735
VISTA in ECs
 Low 60 1
 High 26 0.983 0.582–1.658 0.948
PD-L1
 Low 71 1 1
 High 15 2.951 1.592–5.469 0.001 3.503 1.799–6.821 0.001

HR hazard ratio, CI confidence interval, TC tumor cells, IC immune cells, ECs endothelial cells, PD pancreaticoduodenectomy, DP distal pancreatectomy, TP total pancreatectomy

aBecause small number of cases in these groups, the survival analysis was meaningless